A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer

Condition:   Anal Canal Squamous Cell Carcinoma Interventions:   Drug: BI 754091;   Drug: BI 836880 Sponsor:   Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials